Merk J - Search Results

1

Comparative profiling of the novel epothilone, sagopilone, in xenografts derived from primary non-small cell lung cancer.

Hammer S, Sommer A, Fichtner I, Becker M, Rolff J, Merk J, Klar U, Hoffmann J. Hammer S, et al. Among authors: merk j. Clin Cancer Res. 2010 Mar 1;16(5):1452-65. doi: 10.1158/1078-0432.CCR-09-2455. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179216

2

Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts.

Rolff J, Becker M, Merk J, Hoffmann J, Fichtner I. Rolff J, et al. Among authors: merk j. Target Oncol. 2016 Aug;11(4):507-14. doi: 10.1007/s11523-015-0415-4. Target Oncol. 2016. PMID: 26817645

3

Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?

Merk J, Rolff J, Becker M, Leschber G, Fichtner I. Merk J, et al. Eur J Cardiothorac Surg. 2009 Sep;36(3):454-9. doi: 10.1016/j.ejcts.2009.03.054. Epub 2009 Jun 6. Eur J Cardiothorac Surg. 2009. PMID: 19502076

4

Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.

Fichtner I, Rolff J, Soong R, Hoffmann J, Hammer S, Sommer A, Becker M, Merk J. Fichtner I, et al. Among authors: merk j. Clin Cancer Res. 2008 Oct 15;14(20):6456-68. doi: 10.1158/1078-0432.CCR-08-0138. Clin Cancer Res. 2008. PMID: 18927285 Free article.

5

Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?

Merk J, Rolff J, Dorn C, Leschber G, Fichtner I. Merk J, et al. Eur J Cardiothorac Surg. 2011 Jul;40(1):e29-33. doi: 10.1016/j.ejcts.2011.02.010. Epub 2011 Mar 21. Eur J Cardiothorac Surg. 2011. PMID: 21420313

6

Activation of AMP-activated protein kinase sensitizes lung cancer cells and H1299 xenografts to erlotinib.

Hülsmann HJ, Rolff J, Bender C, Jarahian M, Korf U, Herwig R, Fröhlich H, Thomas M, Merk J, Fichtner I, Sültmann H, Kuner R. Hülsmann HJ, et al. Among authors: merk j. Lung Cancer. 2014 Nov;86(2):151-7. doi: 10.1016/j.lungcan.2014.09.001. Epub 2014 Sep 10. Lung Cancer. 2014. PMID: 25240516

7

Response of Patient-Derived Non-Small Cell Lung Cancer Xenografts to Classical and Targeted Therapies Is Not Related to Multidrug Resistance Markers.

Rolff J, Dorn C, Merk J, Fichtner I. Rolff J, et al. Among authors: merk j. J Oncol. 2009;2009:814140. doi: 10.1155/2009/814140. Epub 2009 Jun 14. J Oncol. 2009. PMID: 19547715 Free PMC article.

8

Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine.

Rivera M, Fichtner I, Wulf-Goldenberg A, Sers C, Merk J, Patone G, Alp KM, Kanashova T, Mertins P, Hoffmann J, Stein U, Walther W. Rivera M, et al. Among authors: merk j. Neoplasia. 2021 Jan;23(1):21-35. doi: 10.1016/j.neo.2020.11.005. Epub 2020 Nov 16. Neoplasia. 2021. PMID: 33212364 Free PMC article.

9

Novel therapies in non-small cell lung cancer.

Zaba O, Grohe C, Merk J. Zaba O, et al. Among authors: merk j. Minerva Chir. 2011 Jun;66(3):235-44. Minerva Chir. 2011. PMID: 21666560 Review.

10

Multitarget FISH and LOH analyses at chromosome 3p in non-small cell lung cancer and adjacent bronchial epithelium.

Woenckhaus M, Grepmeier U, Wild PJ, Merk J, Pfeifer M, Woenckhaus U, Stoelcker B, Blaszyk H, Hofstaedter F, Dietmaier W, Hartmann A. Woenckhaus M, et al. Among authors: merk j. Am J Clin Pathol. 2005 May;123(5):752-61. Am J Clin Pathol. 2005. PMID: 15981815

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters